Home > Healthcare > Medical Devices > Diagnostic Devices > comprehensive metabolic panel testing market
Get a free sample of Comprehensive Metabolic Panel Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Comprehensive Metabolic Panel Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Technological advancements have led to more precise and efficient analytical techniques. These techniques can provide more detailed information from CMP tests, aiding in the diagnosis and monitoring of various health conditions.
The global comprehensive metabolic panel testing industry was valued at USD 12.8 billion in 2022 and is estimated to account for USD 29.5 billion by 2032.
The glucose segment garnered USD 3.1 billion in 2022 and will continue to grow as it provides essential information about an individual's blood sugar levels and is an indicator of various metabolic disorders, including metabolic syndrome.
U.S. comprehensive metabolic panel testing market accounted for USD 4.9 billion in 2022 and is predicted to grow through 2032, primarily attributed to the annual increase in the demand for diagnostic tests, advanced healthcare infrastructure, and leadership in innovative medical practices.
Abbott Laboratories, Quest Diagnostics, Laboratory Corporation of America Holdings Limited, Sonic Healthcare, Unipath, SYNLAB International GmbH, ARUP Laboratories, Genoptix Inc., and Nova Medical among others.